Contemporary Pediatrics sat down with editor-in-chief Dr. Tina Q. Tan to discuss the approval of the COVID-19 vaccine for children aged 5 to 11 years and conversations with parents.
The authorization of the Pfizer/BioNTech COVID-19 vaccine in children aged 5 to 11 years has been met with positive reactions from pediatricians and many parents. As the rollout to the age group starts, allaying safety fears and knowing who to turn to for the vaccine are key. The editor-in-chief of Contemporary Pediatrics, Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, sat down with the editorial team to answer some common questions.
Communication, planning, and vaccines prevent infections in the school setting
July 16th 2024Donna Hallas. PhD, PPCNP-BC, CPNP, PMHS, FAANP, FAAN, underscores the critical need for proper vaccination and effective communication between parents and schools to ensure sick children stay home, while addressing logistical challenges faced by parents.